Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tandem Diabetes Care, Inc. - Common Stock (NQ: TNDM )

33.47 +0.86 (+2.64%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,157,899
Open 32.89
Bid (Size) 33.32 (10)
Ask (Size) 33.50 (3)
Prev. Close 32.61
Today's Range 32.29 - 33.92
52wk Range 22.03 - 53.69
Shares Outstanding 63,029,361
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Tandem Diabetes Care Announces Upcoming Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025
From Tandem Diabetes Care, Inc.
Via Business Wire

Performance

YTD
-6.61%
-6.61%
1 Month
-10.82%
-10.82%
3 Month
+16.38%
+16.38%
6 Month
-26.78%
-26.78%
1 Year
+37.06%
+37.06%

More News

Read More
Tandem Diabetes Care Enters Multi-Year Research Collaboration with UVA Center for Diabetes Technology for Development of Advanced Insulin Delivery Systems
From Tandem Diabetes Care, Inc.
Via Business Wire
Unveiling 8 Analyst Insights On Tandem Diabetes Care
Via Benzinga
The Analyst Verdict: Tandem Diabetes Care In The Eyes Of 5 Experts
Via Benzinga
Analyst Scoreboard: 7 Ratings For Tandem Diabetes Care
Via Benzinga
Tandem t:slim X2 Insulin Pump Now Compatible with Dexcom G7 CGM in Canada
From Tandem Diabetes Care, Inc.
Via Business Wire
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Via Benzinga
Tandem Diabetes Care Announces Upcoming Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Third Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Upcoming Conference Participation
From Tandem Diabetes Care, Inc.
Via Business Wire
This MINISO Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
Tandem Diabetes Care to Announce Third Quarter 2024 Financial Results on November 6, 2024
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Insulin Pump Demand to Surge Despite Popular Demand Of Weight Loss Drugs, Bullish Analyst Says
Via Benzinga
Why Tandem Diabetes Care Stock Took It on the Chin Tuesday
Via The Motley Fool
Why Tandem Diabetes Care Stock Thrashed the Market Today
Via The Motley Fool
Tandem t:slim X2 Insulin Pump Now Compatible with Lyumjev Ultra-rapid Acting Insulin in European Union
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Upcoming Conference Participation
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Release Updated iOS t:connect Mobile App for t:slim X2 Insulin Pump Users Impacted by March 2024 Nationwide Recall
From Tandem Diabetes Care, Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Tandem Diabetes Care Provides Update on March 2024 Nationwide Recall of t:connect Mobile App for iOS Devices
From Tandem Diabetes Care, Inc.
Via Business Wire
TANDEM ALERT: Bragar Eagel & Squire, P.C. is Investigating Tandem Diabetes Care, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Critical Insights From Tandem Diabetes Care Analyst Ratings: What You Need To Know
Via Benzinga
Chips, Glorious Chips!
Via The Motley Fool
Crude Oil Falls Sharply; Exxon Mobil Earnings Top Views
Via Benzinga
Exposures Fossil Fuels
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.